3 results match your criteria: "Dubai Thalassemia Center[Affiliation]"
β-Thalassemia and Diabetes Mellitus: Current State and Future Directions.
Horm Metab Res
April 2024
University of Sharjah College of Health Sciences, Sharjah, United Arab Emirates.
β-Thalassemia major is a congenital hemoglobin disorder that requires regular blood transfusion. The disease is often associated with iron overload and diabetes mellitus, among other complications. Pancreatic iron overload in β-thalassemia patients disrupts β-cell function and insulin secretion and induces insulin resistance.
View Article and Find Full Text PDFInfluence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
Am J Hematol
April 2019
Department of Haematology, University College London, London, United Kingdom.
Hemoglobinopathy carrier prevalence in the United Arab Emirates: first analysis of the Dubai Health Authority premarital screening program results.
Hemoglobin
January 2014
Dubai Thalassemia Center, Dubai Health Authority, Dubai, United Arab Emirates.
The aim of this study was to determine the prevalence of hemoglobinopathy carriers in United Arab Emirates (UAE) nationals subjected to mandatory premarital screening in Dubai over a 4-year period. Data from UAE nationals who underwent premarital screening by the Dubai Health Authority between January 2007 and December 2010 were collected and analyzed. Premarital screening in Dubai is based on complete blood counts (CBC) and hemoglobin (Hb) high performance liquid chromatography (HPLC).
View Article and Find Full Text PDF